FIELD: veterinary science.
SUBSTANCE: the present innovation deals with serological assay for Neospora caninum in animals. It is necessary to detect interaction of animal serum with Neospora caninum-reactive protein in animals being seropositive by the parasite mentioned due to immunoenzamatic solid-phase assay, radio-immune assay and Western-blotting. As protein one should apply either native or recombinant bradyzoid full-size fusion protein out of N.caninum or Toxoplasma gondii or truncated fusion protein or its fragment. The innovation enables to detect serologically N.caninum-seropositive animals being different against vaccinated animals.
EFFECT: higher efficiency.
14 cl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE AGAINST RHIPICEPHALUS TICKS | 2014 |
|
RU2677347C2 |
| CATTLE DIARRHEA VIRUS WITH MODIFIED E PROTEIN | 2009 |
|
RU2524426C2 |
| COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF INFECTION CAUSED BY MICROORGANISM NEISSERIA | 2000 |
|
RU2244749C2 |
| CANINE BABESIOSIS VACCINE ANTIGEN | 2011 |
|
RU2599544C2 |
| EXTRACTED POLYNUCLEOTIDE MOLECULE CODING Torque teno VIRUS, RNA MOLECULE AND EXPRESSION VECTOR | 2009 |
|
RU2502801C2 |
| CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN AND USE THEREOF | 2007 |
|
RU2457217C2 |
| FUSION PROTEIN CONTAINING THYMIC STROMAL LYMPHOPOIETIC PROTEIN, VACCINE CONTAINING EXPRESSION VECTOR FOR EXPRESSION OF PROTEINS AND VACCINE COMPRISING SAID EXPRESSION VECTOR | 2012 |
|
RU2617957C2 |
| IMMUNOGENE COMPOSITION ON BASIS OF ANTIGEN Chlamydia trachomatis (VERSIONS) AND ITS USE | 2004 |
|
RU2352356C2 |
| VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
| STABILISED FMDV CAPSIDS | 2014 |
|
RU2663004C2 |
